These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 3105117)

  • 1. Antitumor activity of lipopolysaccharide in tumor-bearing mice pretreated with BCG.
    Sato H; Ito M; Abe T; Kumano N; Motomiya M; Konno K
    Tohoku J Exp Med; 1986 Dec; 150(4):391-9. PubMed ID: 3105117
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antitumor activity of cyclophosphamide and lipopolysaccharide in tumor-bearing mice pretreated with BCG.
    Sato H; Ito M; Abe T; Kumano N; Motomiya M; Konno K
    Tohoku J Exp Med; 1987 Oct; 153(2):151-60. PubMed ID: 3120354
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chemical analyses and antitumor activity of hydrosoluble substances from Mycobacterium bovis, strain BCG.
    Sato H; Arai H; Nagai H; Ito M; Satoh K; Kumano N; Motomiya M; Konno K
    Tohoku J Exp Med; 1983 May; 140(1):35-43. PubMed ID: 6191409
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [The synergistic action of lipopolysaccharide and muramyl dipeptide in the immunotherapy of DBA/2 mice with mastocytoma P815].
    Rakhmilevich AL; Rakhimova MS
    Biull Eksp Biol Med; 1989 Dec; 108(12):721-4. PubMed ID: 2517487
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Enhancing effect of coenzyme, Q10 on immunorestoration with Mycobacterium bovis BCG in tumor-bearing mice.
    Kawase I; Niitani H; Saijo N; Sasaki H; Morita T
    Gan; 1978 Aug; 69(4):493-7. PubMed ID: 101414
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antitumor activity of Klebsiella 03 lipopolysaccharide in mice.
    Miyamoto K; Koshiura R; Hasegawa T; Kato N
    Jpn J Pharmacol; 1984 Sep; 36(1):51-7. PubMed ID: 6503048
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunotherapy of cancer with cell wall skeleton of Myocabacterium bovis-Bacillus Calmette-Guérin: experimental and clinical results.
    Yamamura Y; Azuma I; Taniyama T; Sugimura K; Hirao F; Tokuzen R; Okabe M; Nakahara W; Yasumoto K; Ohta M
    Ann N Y Acad Sci; 1976; 277(00):209-27. PubMed ID: 826205
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mouse Lewis lung carcinoma and hepatoma ascites treatment by combination of liposome chemotherapy and non-specific immunotherapy.
    Patel KR; Baldeschwieler JD
    Int J Cancer; 1984 Nov; 34(5):717-23. PubMed ID: 6389375
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antitumor effects of bacterial lipopolysaccharide and tumor necrosis factor in mice.
    Moriya N; Miwa H; Orita K
    Jpn J Surg; 1984 Mar; 14(2):163-6. PubMed ID: 6379248
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The augmentation of tumor-specific immunity using haptenic muramyl dipeptide (MDP) derivatives. II. Establishment of tumor-specific immunotherapy models utilizing MDP hapten-reactive helper T cell activity.
    Sano H; Kosugi A; Sano S; Fujiwara H; Hamaoka T
    Cancer Immunol Immunother; 1987; 25(3):180-4. PubMed ID: 2960447
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evidence for host-mediated antitumor activity in the treatment of experimental tumor with a hot water extract from BCG.
    Sato H; Arai H; Nagai H; Ito M; Satoh K; Kumano N; Motomiya M; Konno K
    Tohoku J Exp Med; 1982 Jan; 136(1):67-74. PubMed ID: 7071830
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Upregulation of TNF-alpha and IL-6 mRNA in mouse liver induced by bacille Calmette-Guerin plus lipopolysaccharide.
    Liu DF; Wei W; Song LH
    Acta Pharmacol Sin; 2006 Apr; 27(4):460-8. PubMed ID: 16539847
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Enhanced tumor growth and metastatic spread of an MH134 variant lacking a part of the MM antigen: a possible role of antibody-dependent cellular cytotoxicity in control of tumor growth and metastases.
    Hara H; Kawase I; Komuta K; Masuno T; Kishimoto S
    Int J Cancer; 1989 Jul; 44(1):137-42. PubMed ID: 2744883
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunopotentiation with BCG: dimensions of a specific antitumor response.
    Hawrylko E
    J Natl Cancer Inst; 1975 May; 54(5):1189-97. PubMed ID: 805254
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anti-tumour activity of low-toxicity lipopolysaccharide of Bordetella pertussis.
    Ohnishi M; Kimura S; Yamazaki M; Oshima H; Mizuno DI; Abe S; Yamaguchi H
    Br J Cancer; 1994 Jun; 69(6):1038-42. PubMed ID: 8198967
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Anti-tumor effect of lipopolysaccharide by intradermal administration as a novel drug delivery system.
    Inagawa H; Nishizawa T; Noguchi K; Minamimura M; Takagi K; Goto S; Soma G; Mizuno D
    Anticancer Res; 1997; 17(3C):2153-8. PubMed ID: 9216680
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antitumor activity of peritoneal exudate cells induced by cell-wall skeleton of Mycobacterium bovis BCG.
    Namba M; Ogura T; Hirao F; Azuma I; Yamamura Y
    Gan; 1978 Dec; 69(6):831-4. PubMed ID: 374173
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Influence of BCG in the control of humoral deficiency induced by mastocytoma p-815].
    Bräscher HM; Vargens JR; Maia LC; Oliveira Lima A
    Mem Inst Oswaldo Cruz; 1986; 81(2):149-54. PubMed ID: 3108617
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antitumor effect of bacterial lipopolysaccharide (LPS) alone and in combination with lentinan on MH-134 tumors in C3H/He mice.
    Moriya N; Miwa H; Orita K
    Acta Med Okayama; 1984 Feb; 38(1):49-55. PubMed ID: 6702486
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effector cells of low-dose IL-2 immunotherapy in tumor bearing mice: tumor cell killing by CD8+ cytotoxic T lymphocytes and macrophages.
    Maas RA; Roest PA; Becker MJ; Weimar IS; Dullens HF; Den Otter W
    Immunobiology; 1992 Nov; 186(3-4):214-29. PubMed ID: 1490728
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.